Roberto Cursano
Partner, Delfino e Associati, Global Trade & Investment
Roberto Cursano is a partner focusing on Public Law, Compliance & Investigations and Trade Compliance issues.
A former official of the Italian Ministry of Health, Roberto has significant experience in the healthcare and life sciences industry. He focuses on regulatory matters, including research and development, manufacturing, marketing of medical products, product recalls, interactions with healthcare professionals and organizations and related transparency obligations and litigation before the Supreme Court and the Council of State. Additionally, he assists with the setting-up of compliance models aimed at preventing corruption-related crimes corporate liability.
Roberto participates in training and tutoring in the master’s degree program on clinical trials of pharmaceutical products at the University of Rome Sapienza. He also regularly publishes articles and scientific contributions. He frequently hosts and participates in seminars and presentations on pharmaceutical and administrative law matters.
Experience
- “Market Access & Health Technology Assessment in Italy,” Pharma Boardroom, 2024
- “Orphan Drugs regime in Italy,” Practical Law UK, 2022
-
Italian Chapter, Pharmaceutical Intellectual Property and Competition Law Review, 2020
- “How Foreign Companies Can Protect themselves Against Criminal Liability in Italy,” The Anti-Corruption Report, 2020
- Italian Chapter, The Life Sciences Law Review, 2019
- What Multinationals Need to Know About Italy’s New Whistleblowing Provisions - January 2018, The Anti-Corruption Report, January 2018
- The Italian Organismo di Vigilanza - A Model for an effective compliance committee, FCPA Report, April 2016
- “Global harmonization of combination products Regulation EU vs US,” Clinica, December 2015
Credentials
Education
Università degli Studi di Teramo, PhD, 2010 Istituto Arturo Carlo Jemolo, Post Graduate Diploma, 2000 Sapienza Università di Roma, J.D., 1998